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Recommendations for publication of cross-cultural validation studies of
patient-reported outcomes (PROs) in Osteoarthritis and CartilagePatient-reported outcomes (PROs) constitute the recommended
primary outcome in clinical trials1. Thus a plethora of instruments
have been developed to fulﬁll this need. Today, consensus-based
recommendations are available2 that may serve as guidelines for
development and evaluation of the psychometric properties of
PROs. These recommendations also provide guidance on develop-
ment and evaluation of cross-cultural validation studies of PROs2.
Cross-culturally validated PRO versions are needed to validly study
populations speaking different languages and living in different
cultures using one single instrument. Thus, a linguistic and concep-
tual validation process is needed for translational and cultural
purposes3 and clinical studies are needed to verify the psycho-
metric properties of the new version of the PRO instrument for
the intended study population and purpose.
The purpose of this editorial is to outline recommendations for
publication of cross-cultural validation studies in Osteoarthritis and
Cartilage.
Osteoarthritis and Cartilage is open to submissions of papers
reporting on cross-cultural validation of PROs intended for use in
patients at risk of or with osteoarthritis or other cartilage disease.
Cross-cultural validation studies should preferably be submitted
as brief reports. Submitting a cross-cultural validation study as
a full length paper requires justiﬁcation.
The quality of the study is improved if it is performed and
reported in accordance with the Consensus-based Standards for
the selection of health Measurement Instruments (COSMIN)
checklist2. Following the recommendations of the COSMIN check-
list both when planning the cross-cultural validation study, and
when preparing the manuscript will improve the study and the
chances that your manuscript will be accepted for publication.
We recommend that the “Box G” concerning cross-cultural valida-
tion of the COSMIN checklist is submitted to the editorial ofﬁce
with your manuscript, and that information is provided on where
in your manuscript information on the speciﬁc items are given.
This will facilitate the work of editors and reviewers.
For the purpose of cross-cultural validation, the COSMIN check-
list includes 13 design requirements plus two items referring to
statistical methods. The items relate to the different phases of
cross-cultural validation and include items referring to the
linguistic procedure and items relating to the clinical study
performed. The 15 items are as follows:Design requirements
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3. Was the sample size included in the analysis adequate?
4. Were both the original language in which the instrument was
developed, and the language in which the instrument was
translated described?
5. Was the expertise of the people involved in the translation
process adequately described (e.g., expertise in the disease(s)
involved, expertise in the construct to be measured, expertise
in both languages)?
6. Did the translators work independently from each other?
7. Were items translated forward and backward?
8. Was there an adequate description of how differences between
the original and translated versions were resolved?
9. Was the translation reviewed by a committee (e.g., original
developers)?
10. Was the HR-PRO instrument pre-tested (e.g., cognitive
interviews) to check interpretation, cultural relevance of the
translation, and ease of comprehension?
11. Was the sample used in the pre-test adequately described?
12. Were the samples similar for all characteristics except language
and/or cultural background?
13. Were there any important ﬂaws in the design ormethods of the
study?
Statistical methods
14. For Classical Test Theory: Was conﬁrmatory factor analysis
performed?
15. For Item Response Theory: Was differential item function
between language groups assessed?
While differential item function evaluation is requisite in Item
Response Theory methods, it should be noted that differential
item function can also be evaluated, although not quantiﬁed, on
an item-by-item basis through the use of other methods such as
the chi-square or Fisher’s Exact test.
In addition to using the cross-cultural validation compo-
nent of the COSMIN recommendations for guidance, reliability,
construct validity through relationships with other measures
and responsiveness (if appropriate) should be reported. These
aspects are the subjects of other parts of the COSMIN
checklist.
In summary, cross-culturally validated versions of PROs
intended for patients at risk of or with osteoarthritis and other
diseases of the cartilage are needed to perform clinical studies inblished by Elsevier Ltd. All rights reserved.
Editorial / Osteoarthritis and Cartilage 20 (2012) 4–5 5patients from all over the world. This editorial is intended to
improve the quality of submissions to Osteoarthritis and Cartilage
and in the end enhance clinical research globally.
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